GLP-1 may be more underrated
Semaglutide + B6 is a GLP-1 receptor agonist, meaning it mimics a hormone your body naturally produces (glucagon-like peptide-1) that helps regulate appetite, blood sugar, and how full you feel after eating
Nevertheless, current evidence supports GLP-1 RAs and multi-agonist formulations as highly promising pharmacotherapies that address the complex, multifactorial pathophysiology of MASLD while simultaneously improving cardiometabolic comorbidities, positioning them as cornerstone treatments in the evolving therapeutic landscape for this prevalent and burdensome disease
Glutathione binds to toxins in the liver, allowing them to be excreted more efficiently
After 72 weeks, patients who received up to 6 mg of orforglipron averaged a weight loss of 5.5%, those who received 12 mg averaged 7.8%, and those who received 36 mg averaged 10.5%, while the placebo group averaged just 2.2%
Mukherjee S, Date A, Patravale V, et al
